Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Immunome Inc., 3 years.
Immunome Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immunome Inc. June 10, 202575.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Immunome Inc. | Open-market sale | −11,048 | $27.25 | $301,058 |
| Aug 11, 2026 | Immunome Inc. | Open-market sale | −62,291 | $26.23 | $1,633,893 |
| Aug 10, 2026 | Immunome Inc. | Open-market sale | −10,125 | $26.07 | $263,959 |
| Aug 7, 2026 | Immunome Inc. | Open-market sale | −15,248 | $26.06 | $397,363 |
| Aug 6, 2026 | Immunome Inc. | Open-market sale | −20,840 | $26.06 | $543,090 |
| Jul 7, 2026 | Immunome Inc. | Open-market sale | −16,906 | $24.20 | $409,125 |
| Jul 6, 2026 | Immunome Inc. | Open-market sale | −83,094 | $24.11 | $2,003,396 |
| Jul 2, 2026 | Immunome Inc. | Open-market sale | −75,665 | $22.35 | $1,691,113 |
| Jul 2, 2026 | Immunome Inc. | Open-market sale | −24,335 | $23.33 | $567,736 |
| Jun 30, 2026 | Immunome Inc. | Open-market sale | −101,050 | $21.12 | $2,134,176 |
| Dec 22, 2025 | Immunome Inc. | Open-market sale | −371,949 | $21.72 | $8,078,732 |
| Dec 22, 2025 | Immunome Inc. | Open-market sale | −11,251 | $22.34 | $251,347 |
Questions about Isaac Barchas
What boards is Isaac Barchas on?
Isaac Barchas sits on the board of Immunome Inc.
How long has Isaac Barchas served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.